{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:16:55Z","timestamp":1789787815851,"version":"4.0.1"},"reference-count":0,"publisher":"EDP Sciences","license":[{"start":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T00:00:00Z","timestamp":1554249600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/www.edpsciences.org\/en\/authors\/copyright-and-licensing"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Sci (Paris)"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>Salbutamol, \u00e9ph\u00e9drine, anticholinest\u00e9rasiques ou encore quinidine, diff\u00e9rents m\u00e9dicaments sur le march\u00e9 depuis longtemps sont aujourd\u2019hui prescrits aussi dans les syndromes myasth\u00e9niques cong\u00e9nitaux, avec une efficacit\u00e9 remarquable. Ils ont transform\u00e9 la prise en charge et le pronostic. Reste que les obtenir rel\u00e8ve pour le patient et son m\u00e9decin d\u2019un parcours sem\u00e9 de nombreux obstacles.<\/jats:p>","DOI":"10.1051\/medsci\/2019022","type":"journal-article","created":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T13:35:04Z","timestamp":1554298504000},"page":"28-31","source":"Crossref","is-referenced-by-count":2,"special_numbering":"Hors s\u00e9rie n\u00b0 1","title":["Syndromes myasth\u00e9niques cong\u00e9nitaux: Le repositionnement ne simplifie pas <i>de facto<\/i> l\u2019acc\u00e8s"],"prefix":"10.1051","volume":"35","author":[{"given":"Bruno","family":"Eymard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"250","published-online":{"date-parts":[[2019,4,3]]},"container-title":["m\u00e9decine\/sciences"],"original-title":[],"link":[{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2019022\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T19:37:44Z","timestamp":1584646664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.medecinesciences.org\/10.1051\/medsci\/2019022"}},"subtitle":["Utilisation clinique des traitements innovants, repositionn\u00e9s ou hors AMM : le v\u00e9cu du terrain (4)"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":0,"alternative-id":["medsci190022s"],"URL":"https:\/\/doi.org\/10.1051\/medsci\/2019022","relation":{},"ISSN":["0767-0974","1958-5381"],"issn-type":[{"value":"0767-0974","type":"print"},{"value":"1958-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}